194 related articles for article (PubMed ID: 29229995)
1. Lysyl oxidase-like 3 is required for melanoma cell survival by maintaining genomic stability.
Santamaría PG; Floristán A; Fontanals-Cirera B; Vázquez-Naharro A; Santos V; Morales S; Yuste L; Peinado H; García-Gómez A; Portillo F; Hernando E; Cano A
Cell Death Differ; 2018 May; 25(5):935-950. PubMed ID: 29229995
[TBL] [Abstract][Full Text] [Related]
2. LOXL3 Silencing Affected Cell Adhesion and Invasion in U87MG Glioma Cells.
Laurentino TS; Soares RDS; Lerario AM; Marie SKN; Oba-Shinjo SM
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360836
[TBL] [Abstract][Full Text] [Related]
3. LOXL3 Function Beyond Amino Oxidase and Role in Pathologies, Including Cancer.
Laurentino TS; Soares RDS; Marie SKN; Oba-Shinjo SM
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31340433
[TBL] [Abstract][Full Text] [Related]
4. Significance of the Lysyl Oxidase Members Lysyl Oxidase Like 1, 3, and 4 in Gastric Cancer.
Kasashima H; Yashiro M; Okuno T; Miki Y; Kitayama K; Masuda G; Kinoshita H; Morisaki T; Fukuoka T; Hasegawa T; Sakurai K; Toyokawa T; Kubo N; Tanaka H; Muguruma K; Hirakawa K; Ohira M
Digestion; 2018; 98(4):238-248. PubMed ID: 30045039
[TBL] [Abstract][Full Text] [Related]
5. A tissue-specific variant of the human lysyl oxidase-like protein 3 (LOXL3) functions as an amine oxidase with substrate specificity.
Lee JE; Kim Y
J Biol Chem; 2006 Dec; 281(49):37282-90. PubMed ID: 17018530
[TBL] [Abstract][Full Text] [Related]
6. N6-methyladenosine reader YTHDF3 regulates melanoma metastasis via its 'executor'LOXL3.
Shi HZ; Xiong JS; Gan L; Zhang Y; Zhang CC; Kong YQ; Miao QJ; Tian CC; Li R; Liu JQ; Zhang EJ; Bu WB; Wang Y; Cheng XF; Sun JF; Chen H
Clin Transl Med; 2022 Nov; 12(11):e1075. PubMed ID: 36324258
[TBL] [Abstract][Full Text] [Related]
7. Loxl3 Promotes Melanoma Progression and Dissemination Influencing Cell Plasticity and Survival.
Vázquez-Naharro A; Bustos-Tauler J; Floristán A; Yuste L; Oltra SS; Vinyals A; Moreno-Bueno G; Fabra À; Portillo F; Cano A; Santamaría PG
Cancers (Basel); 2022 Feb; 14(5):. PubMed ID: 35267510
[TBL] [Abstract][Full Text] [Related]
8. Identification of LOXL3-associating immune infiltration landscape and prognostic value in hepatocellular carcinoma.
Wang N; Zhou X; Tang F; Wang X; Zhu X
Virchows Arch; 2021 Dec; 479(6):1153-1165. PubMed ID: 34448895
[TBL] [Abstract][Full Text] [Related]
9. Loxl2 and Loxl3 Paralogues Play Redundant Roles during Mouse Development.
Santamaría PG; Dubus P; Bustos-Tauler J; Floristán A; Vázquez-Naharro A; Morales S; Cano A; Portillo F
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628534
[TBL] [Abstract][Full Text] [Related]
10. LOXL3-sv2, a novel variant of human lysyl oxidase-like 3 (LOXL3), functions as an amine oxidase.
Jeong C; Kim Y
Int J Mol Med; 2017 Mar; 39(3):719-724. PubMed ID: 28112368
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemistry analysis reveals lysyl oxidase-like 3 as a novel prognostic marker for primary melanoma.
Zhang X; Su MW; Cheng Y; Martinka M; Wang G; Huang Y; Li L; Zhou Y
Melanoma Res; 2021 Apr; 31(2):173-177. PubMed ID: 33625099
[TBL] [Abstract][Full Text] [Related]
12. CEBPA facilitates LOXL2 and LOXL3 transcription to promote BCL-2 stability and thus enhances the growth and metastasis of lung carcinoma cells in vitro.
Fan L; Jiang W; Chen C; Gao H; Shi J; Wang D
Exp Cell Res; 2024 Feb; 435(2):113937. PubMed ID: 38242344
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis Activation and Autophagy Inhibition of Chondrocytes by Leptin by the Upregulation of LOXL3 in Osteoarthritis Pathogenesis.
Wei Q
J Healthc Eng; 2022; 2022():4026128. PubMed ID: 35035830
[TBL] [Abstract][Full Text] [Related]
14. Reverse transcriptase inhibition potentiates target therapy in BRAF-mutant melanomas: effects on cell proliferation, apoptosis, DNA-damage, ROS induction and mitochondrial membrane depolarization.
Fattore L; Malpicci D; Milite C; Castellano S; Sbardella G; Botti G; Ascierto PA; Mancini R; Ciliberto G
Cell Commun Signal; 2020 Sep; 18(1):150. PubMed ID: 32933538
[TBL] [Abstract][Full Text] [Related]
15. Progressive degeneration of the retina in Loxl3 mutant mouse model of Stickler syndrome.
Liu Z; Mo F; Dong X; Chen G; Gao J; Zhang J
Dev Biol; 2023 Mar; 495():54-62. PubMed ID: 36610533
[TBL] [Abstract][Full Text] [Related]
16. Exoenzyme C3 transferase lowers actin cytoskeleton dynamics, genomic stability and survival of malignant melanoma cells under UV-light stress.
Magalhaes YT; Cardella GD; Forti FL
J Photochem Photobiol B; 2020 Aug; 209():111947. PubMed ID: 32652466
[TBL] [Abstract][Full Text] [Related]
17. The cytoskeleton protein filamin-A is required for an efficient recombinational DNA double strand break repair.
Yue J; Wang Q; Lu H; Brenneman M; Fan F; Shen Z
Cancer Res; 2009 Oct; 69(20):7978-85. PubMed ID: 19808958
[TBL] [Abstract][Full Text] [Related]
18. Defective cell cycle checkpoint functions in melanoma are associated with altered patterns of gene expression.
Kaufmann WK; Nevis KR; Qu P; Ibrahim JG; Zhou T; Zhou Y; Simpson DA; Helms-Deaton J; Cordeiro-Stone M; Moore DT; Thomas NE; Hao H; Liu Z; Shields JM; Scott GA; Sharpless NE
J Invest Dermatol; 2008 Jan; 128(1):175-87. PubMed ID: 17597816
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic BRAF(V600E) inhibits BIM expression to promote melanoma cell survival.
Cartlidge RA; Thomas GR; Cagnol S; Jong KA; Molton SA; Finch AJ; McMahon M
Pigment Cell Melanoma Res; 2008 Oct; 21(5):534-44. PubMed ID: 18715233
[TBL] [Abstract][Full Text] [Related]
20. Evolving roles of lysyl oxidase family in tumorigenesis and cancer therapy.
Ye M; Song Y; Pan S; Chu M; Wang ZW; Zhu X
Pharmacol Ther; 2020 Nov; 215():107633. PubMed ID: 32693113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
